RPCONE
CRBP icon

Retirement Planning Company of New England’s Corbus Pharmaceuticals CRBP Stock Holding History

Retirement Planning Company of New England’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed – – 347
2021
Q4 		$0 Buy
+3
New +$81 ﹤0.01% 920

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Retirement Planning Company of New England's CRBP Position: Q1 2022 in Review

Retirement Planning Company of New England sold out of Corbus Pharmaceuticals (CRBP) in Q1 2022, closing a stake of 3 shares.

Retirement Planning Company of New England first reported a position in CRBP in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 72 funds tracked by Wall St. Rank hold CRBP as of Q1 2022.

  • Retirement Planning Company of New England reported no remaining Corbus Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Retirement Planning Company of New England sold 3 Corbus Pharmaceuticals shares in Q1 2022.
  • Retirement Planning Company of New England first reported a position in Corbus Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Retirement Planning Company of New England's Corbus Pharmaceuticals position peaked at $0 in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2022.

Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.